EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer. Okamura S, Yoshino H, Kuroshima K, Tsuruda M, et al. BMC Cancer 2021;21:48.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Okamura S, Yoshino H, Kuroshima K, Tsuruda M, et al. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer. BMC Cancer 2021;21:48.
PMID: 33430801